Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

FDA Takes Aim at Delaying Tactics for Shared REMS

  • Post author:Sam
  • Post published:December 18, 2017
  • Post category:Generic Line

The FDA is working to prevent manufacturers of branded high-risk drugs from stalling an application for approval of a generic competitor via manipulation of a requirement to share safety programs,…

Continue ReadingFDA Takes Aim at Delaying Tactics for Shared REMS

J&J Sued for Blocking Biosimilar Remicade Competition

  • Post author:Sam
  • Post published:December 18, 2017
  • Post category:Generic Line

A workers’ benefits fund filed a lawsuit claiming Johnson & Johnson maintained an illegal monopoly for its blockbuster drug Remicade, employing anticompetitive schemes involving insurer contracts, rebate protocols and bundling.…

Continue ReadingJ&J Sued for Blocking Biosimilar Remicade Competition

UK Watchdog Claims Concordia Overcharged for Thyroid Generic

  • Post author:Sam
  • Post published:December 18, 2017
  • Post category:Generic Line

The UK’s competition watchdog agency claimed the drugmaker Concordia overcharged the NHS by millions for its hypothyroid medication liothyronine, also known as Cytomel, following price increases of almost 6,000 percent…

Continue ReadingUK Watchdog Claims Concordia Overcharged for Thyroid Generic

Chiome Bioscience, Chugai Pharma Terminate Partnership

  • Post author:Sam
  • Post published:December 17, 2017
  • Post category:BioPharma

Chiome Bioscience says it announces termination of candidate antibody related joint research contract, which was signed between the co and Chugai Pharma, as the contract has expired on Dec. 31…

Continue ReadingChiome Bioscience, Chugai Pharma Terminate Partnership

8 Possible Biopharma Takeover Targets for 2018

  • Post author:Sam
  • Post published:December 17, 2017
  • Post category:BioPharma

The possibility of a tax bill being passed has many investors and analysts forecasting 2018 to be a big year for mergers and acquisitions. Source: BioSpace

Continue Reading8 Possible Biopharma Takeover Targets for 2018

Intellia Therapeutics Gets New Chief

  • Post author:Sam
  • Post published:December 17, 2017
  • Post category:BioPharma

Intellia has named John Leonard, M.D., President and CEO, effective January 1, 2018. Source: BioSpace

Continue ReadingIntellia Therapeutics Gets New Chief

Boehringer Inks €627.5M Deal With GlaxoSmithKline Spinout

  • Post author:Sam
  • Post published:December 17, 2017
  • Post category:BioPharma

Under terms of the deal, Boehringer has the option to acquire Autifony's Kv3.1/3.2 positive modulator platform, which includes the company's lead compound AUT00206. Source: BioSpace

Continue ReadingBoehringer Inks €627.5M Deal With GlaxoSmithKline Spinout

12 Clinical Successes of 2017

  • Post author:Sam
  • Post published:December 17, 2017
  • Post category:BioPharma

Now that we've got the bad news out of the way, we’re here to spread some Christmas cheer with the biggest clinical successes in biotech over the past 12 months.…

Continue Reading12 Clinical Successes of 2017

Neurotrope Poaches Forest Lab Exec to Be CEO

  • Post author:Sam
  • Post published:December 17, 2017
  • Post category:BioPharma

Dr. Ryan becomes a Director of the Company effective immediately and will assume his responsibilities as CEO effective February 15, 2018. Source: BioSpace

Continue ReadingNeurotrope Poaches Forest Lab Exec to Be CEO

Aptinyx Bags $70M Financing to Fuel Expanding Pipeline

  • Post author:Sam
  • Post published:December 17, 2017
  • Post category:BioPharma

The round was led by Bain Capital Life Sciences. Source: BioSpace

Continue ReadingAptinyx Bags $70M Financing to Fuel Expanding Pipeline
  • Go to the previous page
  • 1
  • …
  • 223
  • 224
  • 225
  • 226
  • 227
  • 228
  • 229
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.